[Examination of the oral cavities of patients with cancer: clinical evaluation and indirect measurement of the nitric oxide level]. / Exame da cavidade bucal de pacientes com câncer: avaliação clínica e dosagem indireta de óxido nítrico.

This observational study aimed to verify the association between the clinical state of the oral cavity (based on the Index of Decayed, Missing, and Filled Teeth and the Simplified Oral Hygiene Index) and the indirectly determined nitric oxide level in patients with oncologic and hematologic diseases. This study included 20 hospitalized patients who were in the evaluation phase prior to starting chemotherapy and who had been diagnosed with leukemia (35%), lymphoma (50%) or myeloma (15%). Fifty percent of these patients had normal oral health (no injury or trauma), and most had satisfactory (35%) or typical (35%) hygiene, but 30% had poor or very poor hygiene. The indirectly measured levels of nitric oxide ranged from 13.34 to 257. The nitric oxide level was not associated with other parameters, and there was great variability in its level. Further studies are necessary given the potential of using this indicator in the early detection of oral diseases.

Exame da cavidade bucal de pacientes com câncer: avaliação clínica e dosagem indireta de óxido nítrico / Examination of the oral cavities of patients with cancer: clinical evaluation and indirect measurement of the nitric oxide level / Examen de la cavidad oral de los pacientes con cáncer: evaluación clínica y medición indirecta de óxido nítrico

Neste estudo buscou-se verificar associação entre avaliação clínica da cavidade oral (pelos Índices de dentes Cariados,Perdidos e Obturados e Índice de Higiene Oral - Simplificado) e a determinação indireta de óxido nítrico em pacientes com patologias onco-hematológicas. Trata-se de estudo observacional, no qual foram incluídos vinte sujeitos internados, diagnosticados com Leucemia (35%), Linfoma (50%), Mieloma (15%), em avaliação para início de quimioterapia, sendo que 50% apresentaram normalidade da condição bucal (sem lesões ou traumas); a maioria apresentou higiene satisfatória (35%) ou regular (35%), porém, 30% tiveram higiene deficiente ou péssima. A expressão indireta do óxido nítrico variou de 13,34 a 257. O óxido nítrico não apresentou associação com os outros parâmetros; houve grande variabilidade de seus valores. Novos estudos são necessários, em especial pela potencialidade deste indicador na detecção precoce de alterações bucais.

This observational study aimed to verify the association between the clinical state of the oral cavity (based on the Index of Decayed, Missing, and Filled Teeth and the Simplified Oral Hygiene Index) and the indirectly determined nitric oxide level in patients with oncologic and hematologic diseases. This study included 20 hospitalized patients who were in the evaluation phase prior to starting chemotherapy and who had been diagnosed with leukemia (35%), lymphoma (50%) or myeloma (15%). Fifty percent of these patients had normal oral health (no injury or trauma), and most had satisfactory (35%) or typical (35%) hygiene, but 30% had poor or very poor hygiene. The indirectly measured levels of nitric oxide ranged from 13.34 to 257. The nitric oxide level was not associated with other parameters, and there was great variability in its level. Further studies are necessary given the potential of using this indicator in the early detection of oral diseases.

Este estudio observacional buscó verificar la asociación entre evaluación clínica de la cavidad oral (por medio de el índice de dientes cariados, perdidos y obturados y el índice de higiene oral simplificado) y la determinación indirecta de óxido nítrico en pacientes con enfermedades oncohematológicas. Estudio observacional, que incluyó a 20 pacientes hospitalizados, con diagnóstico de leucemia (35%), linfoma (50%), mieloma (15%), bajo evaluación para el inicio de la quimioterapia, de los cuales el 50% tenía salud bucal normal (sin lesión o trauma). La mayoría mostró higiene satisfactoria (35%) o regular (35%), pero el 30% tenía mala o muy mala higiene. La expresión indirecta del óxido nítrico varió de 13,34 hasta 257. El óxido nítrico no presentó asociación con otros parámetros, hubo gran variabilidad de los valores. Se necesitan más estudios, en particular, el potencial de este indicador para la detección precoz de las enfermedades bucodentales.

Use of therapeutic laser for prevention and treatment of oral mucositis.

Oral mucositis (OM) affects patients who are submitted to hematopoietic stem cell transplantation (HSCT) due to high doses of chemotherapy and/or radiotherapy. The purpose of this investigation was to perform a comparative study of the frequency and evolution of OM among patients subjected to therapeutic laser and to the conventional therapy (use of mouthwash called 'Mucositis Formula'). The patients were subjected to a myeloablative conditioning regimen before the allogeneic HSCT. Twenty-two patients were selected and divided into 2 groups: group I was irradiated with InGaAlP laser (660 nm) and GaAlAs laser (780 nm), 25 mW potency, 6.3J/cm(2) dose, in 10-s irradiation time, followed to conventional treatment; group II was subjected only to the conventional treatment. Both World Health Organization (WHO) scale and the Oral Mucositis Assessment Scale (OMAS) were used to evaluate the results. Data were analyzed by the non-parametric Wilcoxon test, with p<0.05 considered as statistically significant. Group I presented a lower frequency of OM (p=0.02) and lower mean scores, according to WHO and OMAS scales (p<0.01 and p=0.01, respectively). In conclusion, laser reduced the frequency and severity of OM, suggesting that therapeutic laser can be used both as a new form of prevention and treatment of OM.

Use of therapeutic laser for prevention and treatment of oral mucositis

Oral mucositis (OM) affects patients who are submitted to hematopoietic stem cell transplantation (HSCT) due to high doses of chemotherapy and/or radiotherapy. The purpose of this investigation was to perform a comparative study of the frequency and evolution of OM among patients subjected to therapeutic laser and to the conventional therapy (use of mouthwash called "Mucositis Formula"). The patients were subjected to a myeloablative conditioning regimen before the allogeneic HSCT. Twenty-two patients were selected and divided into 2 groups: group I was irradiated with InGaAlP laser (660 nm) and GaAlAs laser (780 nm), 25 mW potency, 6.3J/cm² dose, in 10-s irradiation time, followed to conventional treatment; group II was subjected only to the conventional treatment. Both World Health Organization (WHO) scale and the Oral Mucositis Assessment Scale (OMAS) were used to evaluate the results. Data were analyzed by the non-parametric Wilcoxon test, with p<0.05 considered as statistically significant. Group I presented a lower frequency of OM (p=0.02) and lower mean scores, according to WHO and OMAS scales (p<0.01 and p=0.01, respectively). In conclusion, laser reduced the frequency and severity of OM, suggesting that therapeutic laser can be used both as a new form of prevention and treatment of OM.

A mucosite oral (MO) afeta pacientes que são submetidos ao transplante de células-tronco hematopoéticas (TCTH) devido as altas doses de quimioterapia e/ou radioterapia. A proposta desta investigação foi realizar um estudo comparativo da freqüência e a evolução da MO entre os pacientes submetidos ao laser terapêutico e da terapia convencional (uso de solução de bochecho chamada "Fórmula para Mucosite").Os pacientes foram submetidos ao regime de condicionamento mieloablativo antes da realização do TCTH alogênico.Vinte e dois pacientes foram selecionados e divididos em 2 grupos: grupo I foi irradiado com laser AlGaInP (660 nm) e laser GaAlAs (780 nm), potência de 25 mW, dose de 6,3J/cm², tempo 10 s, seguido do tratamento convencional; grupo II submetido apenas ao tratamento convencional. Ambas as escalas da World Health Organization (WHO) e Oral Mucositis Assessment Scales (OMAS) foram utilizadas para avaliar os resultados. Os dados foram analizados pelo teste não-paramétrico de Wilcoxon, com p<0,05 considerado estatisticamente significante. O grupo I apresentou menor frequência de MO (p=0,02) e menor média de acordo com as escalas WHO e OMAS (p<0,01 e p=0,01, respectivamente). Em conclusão, o laser reduziu a frequência e gravidade da MO, sugerindo que o laser terapêutico pode ser usado para ambos como uma nova forma de prevenção e tratamento da MO.